Last Price$20.72.1%
Market Cap$972.8M
1M Return
(3.4%)
vs (8.2%) S&P 500
YTD Return
38.9%
vs 17.5% S&P 500
1Y Return
53.5%
vs 8.9% S&P 500
3Y Return
229.5%
vs 32.5% S&P 500
ELVN Momentum Rating
ELVN Momentum rating
9.1
ELVN Momentum rating performance
ELVN Price Performance and Momentum
Crunching data... Almost there!
Competing with ELVN Stock Price Performance
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Momentum score | Last Price | 52w high | 52w low | 1d change | 1w change | 1m change | 3m change | 6m change | 1y change | 3y change | 5y change | 10y change | 3y CAGR | 5y CAGR | 10y CAGR | % of 52w high | % of 52w low |
$972.8M | 9.1 | $20.7 2.1% | $29.6 | $11.5 | 2.1% | 3.9% | (3.4%) | (14.1%) | (10.3%) | 53.5% | 229.5% | (65.5%) | (65.5%) | 48.8% | (23.4%) | (23.4%) | 70.0% | 179.3% | |
$124.8B | 3.0 | $488.3 (2.3%) | $516.7 | $392.8 | (2.3%) | 0.4% | 7.3% | 4.3% | 2.9% | 17.8% | 106.5% | 121.6% | 298.2% | 27.3% | 17.3% | 14.8% | 94.5% | 124.3% | |
$77.0B | 4.1 | $718.2 (3.6%) | $1,200.2 | $663.0 | (3.6%) | 6.3% | 8.1% | (7.0%) | (37.0%) | (25.4%) | 11.9% | 54.7% | 69.4% | 3.8% | 9.1% | 5.4% | 59.8% | 108.3% | |
$34.4B | 9.1 | $580.4 1.7% | $671.8 | $356.0 | 1.7% | (6.6%) | (8.7%) | (4.2%) | 8.0% | 50.8% | 108.6% | 333.8% | 2,423.6% | 27.8% | 34.1% | 58.6% | 86.4% | 163.0% | |
$30.7B | 4.6 | $238.7 2.4% | $300.6 | $143.3 | 2.4% | (1.7%) | (11.2%) | (6.1%) | (8.8%) | 60.1% | 54.1% | 134.3% | 110.2% | 15.5% | 18.6% | 7.7% | 79.4% | 166.6% | |
$24.0B | 5.8 | $98.4 (6.6%) | $126.9 | $78.4 | (6.6%) | (10.3%) | (14.1%) | (17.6%) | (0.9%) | 2.2% | (26.5%) | 209.9% | 600.1% | (9.8%) | 25.4% | 47.6% | 77.5% | 125.6% | |
$14.5B | 2.3 | $32.5 (0.9%) | $33.9 | $24.1 | (0.9%) | (2.6%) | 1.3% | 29.7% | 18.6% | 11.2% | (8.4%) | (19.0%) | (19.0%) | (2.9%) | (5.1%) | (5.1%) | 95.9% | 134.6% | |
$13.8B | 7.5 | $304.4 (4.2%) | $410.0 | $228.3 | (4.2%) | (1.4%) | (13.8%) | (15.9%) | (12.1%) | 22.0% | 76.0% | 223.9% | 86.9% | 20.7% | 26.5% | 6.5% | 74.2% | 133.4% | |
$13.4B | 3.4 | $70.5 (2.1%) | $93.8 | $61.3 | (2.1%) | (0.0%) | 10.9% | 6.9% | (16.9%) | (18.0%) | (7.2%) | (18.9%) | (38.4%) | (2.5%) | (4.1%) | (4.7%) | 75.1% | 115.1% | |
$13.3B | 8.0 | $18.5 2.8% | $31.9 | $2.4 | 2.8% | (3.1%) | (3.0%) | (1.4%) | (18.5%) | 330.2% | 563.1% | 878.8% | 68.3% | 87.9% | 57.8% | 5.3% | 57.9% | 774.1% | |
$1,846.9M | 9.0 | $226.7 0.0% | $246.0 | $129.5 | 0.0% | 2.0% | 23.3% | 4.7% | 40.9% | 39.9% | (6.5%) | 45.2% | 700.5% | (3.3%) | 7.7% | 29.7% | 92.1% | 175.0% |
FAQ
1. What is Enliven Therapeutics, Inc. (ELVN) 1-month return?
Enliven Therapeutics, Inc. (ELVN) 1-month return is (3.4%), compared to the (8.2%) return of the S&P 500.
2. What is Enliven Therapeutics, Inc. (ELVN) year-to-date (YTD) return?
Enliven Therapeutics, Inc. (ELVN) YTD return is 38.9%, compared to the 17.5% return of the S&P 500.
3. What is Enliven Therapeutics, Inc. (ELVN) 1-year return?
Enliven Therapeutics, Inc. (ELVN) 1-year return is 53.5%, compared to the 8.9% return of the S&P 500.
4. What is Enliven Therapeutics, Inc. (ELVN) 3-year return?
Enliven Therapeutics, Inc. (ELVN) 3-year return is 229.5%, compared to the 32.5% return of the S&P 500.